{
  "drug_name": "Intralipid",
  "url": "https://wikem.org/wiki/Intralipid",
  "scraped_at": "2026-01-10T07:55:38.170788",
  "sections": {
    "General": {
      "text": "Type: Lipid emulsion therapy\nDosage Forms: 10%, 20%, and 30% lipid emulsions\nNote that 20% is used for lipid rescue therapy for systemic drug toxicity\n[1]\nRoutes of Administration: IV\nCommon Trade Names: Intralipid, Lipid Rescue\n[2]",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adult_Dosing": {
      "text": "Note that dosing for adults and children is not standardized but is based on case reports and recommendations\n[3]\n1.5 mL/kg bolus over 1 minute\n[4]\n[5]\nNote that dosing is based on lean or ideal body mass\n[6]\nFollowed by 0.25 mL/kg/min for 20 min or until hemodynamic stability is achieved.\n[7]",
      "subsections": {
        "Persistent_Cardiovascular_Collapse": {
          "text": "May repeat bolus once or twice for persistent cardiovascular collapse\n[8]\nMay double rate of infusion to 0.5 mL/kg/min for persistent hypotension\n[9]\nMax cumulative dose: 12 ml/kg",
          "tables": []
        },
        "After_Cardiovascular_Stability_Achieved": {
          "text": "Maintain infusion for at least 10 minutes\n[10]",
          "tables": []
        },
        "Simplified_Protocol": {
          "text": "Based on 'average' 70 kg patient\n100 mL IV bolus over 1 minute\nInfusion at 18 mL/h IV",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Persistent_Cardiovascular_Collapse": {
      "text": "May repeat bolus once or twice for persistent cardiovascular collapse\n[8]\nMay double rate of infusion to 0.5 mL/kg/min for persistent hypotension\n[9]\nMax cumulative dose: 12 ml/kg",
      "subsections": {
        "After_Cardiovascular_Stability_Achieved": {
          "text": "Maintain infusion for at least 10 minutes\n[10]",
          "tables": []
        },
        "Simplified_Protocol": {
          "text": "Based on 'average' 70 kg patient\n100 mL IV bolus over 1 minute\nInfusion at 18 mL/h IV",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "After_Cardiovascular_Stability_Achieved": {
      "text": "Maintain infusion for at least 10 minutes\n[10]",
      "subsections": {
        "Simplified_Protocol": {
          "text": "Based on 'average' 70 kg patient\n100 mL IV bolus over 1 minute\nInfusion at 18 mL/h IV",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Simplified_Protocol": {
      "text": "Based on 'average' 70 kg patient\n100 mL IV bolus over 1 minute\nInfusion at 18 mL/h IV",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "As with adults, pediatric dosing is not standardized\n[12]\nInitial bolus of 0.8 - 3 mL/kg\n[13]\nNo recommendations provided for rate of ongoing infusion",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation risk\n:\nRenal Dosing\nAdult\nPediatric\nHepatic Dosing\nAdult\nPediatric",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Asystole (case reported)\n[16]\nFat embolism\nHypersensitivity reactions\nARDS",
          "tables": []
        },
        "Common": {
          "text": "Pancreatitis\n[17]\nHypertriglyceridemia\n[17]\nInterferes with some lab measurements\nGlucose and magnesium concentrations become inaccurate\nCreatinine and lipase become unmeasurable",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Pancreatitis",
          "url": "https://wikem.org/wiki/Pancreatitis"
        }
      ]
    },
    "Serious": {
      "text": "Asystole (case reported)\n[16]\nFat embolism\nHypersensitivity reactions\nARDS",
      "subsections": {
        "Common": {
          "text": "Pancreatitis\n[17]\nHypertriglyceridemia\n[17]\nInterferes with some lab measurements\nGlucose and magnesium concentrations become inaccurate\nCreatinine and lipase become unmeasurable",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Pancreatitis",
          "url": "https://wikem.org/wiki/Pancreatitis"
        }
      ]
    },
    "Common": {
      "text": "Pancreatitis\n[17]\nHypertriglyceridemia\n[17]\nInterferes with some lab measurements\nGlucose and magnesium concentrations become inaccurate\nCreatinine and lipase become unmeasurable",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pancreatitis",
          "url": "https://wikem.org/wiki/Pancreatitis"
        }
      ]
    },
    "Pharmacology": {
      "text": "Half-life:\nMetabolism:\nExcretion:\nMechanism of Action:\nUnclear, but proposed mechanisms include\n[18]\n:\nLipid sink/partition\nEmulsion surrounds lipophilic drug molecule, partitioning it from target organs\nCardiac metabolism\nFatty acids provide the myocardium with a ready energy source, improving cardiac contractility",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Comments": {
      "text": "Avoid co-administration of:\n[19]\nVasopressin\nCalcium channel blockers\nBeta-blockers\nLocal anesthetics\nHigh-dose\nepinephrine\nPropofol",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Vasopressin",
          "url": "https://wikem.org/wiki/Vasopressin"
        },
        {
          "text": "Calcium channel blockers",
          "url": "https://wikem.org/wiki/Calcium_channel_blockers"
        },
        {
          "text": "Beta-blockers",
          "url": "https://wikem.org/wiki/Beta-blockers"
        },
        {
          "text": "Local anesthetics",
          "url": "https://wikem.org/wiki/Local_anesthetics"
        },
        {
          "text": "epinephrine",
          "url": "https://wikem.org/wiki/Epinephrine"
        },
        {
          "text": "Propofol",
          "url": "https://wikem.org/wiki/Propofol"
        }
      ]
    },
    "See_Also": {
      "text": "Beta-blocker toxicity\nCalcium channel blocker toxicity\nLocal Anesthetic Systemic Toxicity (LAST)\nTricyclic antidepressant toxicity",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Beta-blocker toxicity",
          "url": "https://wikem.org/wiki/Beta-blocker_toxicity"
        },
        {
          "text": "Calcium channel blocker toxicity",
          "url": "https://wikem.org/wiki/Calcium_channel_blocker_toxicity"
        },
        {
          "text": "Local Anesthetic Systemic Toxicity (LAST)",
          "url": "https://wikem.org/wiki/Local_Anesthetic_Systemic_Toxicity_(LAST)"
        },
        {
          "text": "Tricyclic antidepressant toxicity",
          "url": "https://wikem.org/wiki/Tricyclic_antidepressant_toxicity"
        }
      ]
    },
    "External_Links": {
      "text": "LipidRescue",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}